Kalil Abdullah MD

Kalil G. Abdullah, MD, MSc, is a neurosurgeon specializing in the treatment of adult brain tumors and is the director of translational neuro-oncology at the UPMC Hillman Cancer Center. Dr. Abdullah treats brain tumors using microsurgery techniques and awake craniotomies to map intricate regions of the brain during surgery. He also uses endoscopic and tubular approaches, intraoperative fluorescence, and laser therapy to provide minimally invasive surgery options to his patients

Dr. Abdullah is an NIH-funded investigator and directs the department’s Translational Neuro-Oncology Laboratory, developing new drugs and treatment targets for brain cancers. He has been the principal investigator for numerous clinical trials for glioma and is actively involved in bringing promising brain tumor drugs from the laboratory to early-stage clinical trials. He has published more than 100 research articles including key neuro-oncology advances in journals such as Neuro-Oncology, Cancer Cell, Nature Medicine, and Clinical Cancer Research, and co-edited Glioblastoma, a seminal textbook on malignant gliomas.

Dr. Abdullah earned his medical degree at the Cleveland Clinic Lerner College of Medicine, where he was a National Institutes of Health Howard Hughes Medical Institute Scholar. He completed a residency in neurological surgery at the University of Pennsylvania and then received advanced training in open and endoscopic neurosurgical oncology through a fellowship at the Wellington Hospital in New Zealand. He completed an additional postdoctoral research fellowship in stem cell biology at the University of Pennsylvania and holds a master’s degree from the London School of Economics.